SlideShare a Scribd company logo
1 of 52
Download to read offline
Analyzing Data in
Health Care
Dr. Majdi N. Al-Jasim
SBFM, ABFM
Consultant Family Medicine
PCFCM - AlAhsa
Scenario
56 year-old woman came to you to discuss her
mammogram study result. Her result was
positive and so she asked you “Oh, do I have
breast cancer doctor?”
How will you respond to this question?
Continue…
You searched the literature and you found that the
prevalence of breast cancer in KSA in 2015 was 14% among
women age 45-59 years old. Further more, you knew that
the sensitivity of mammogram is about 98% at this age
group while the specificity is 82%.
Can You answer the woman previous question now?
YOU!
OBJECTIVES
1. To discuss the general steps of data analysis in health care.
2. To discuss the important fundamental terms used in data
analysis of health problem, lab or imaging studies:
▪Prevalence, Incidence, Sensitivity, Specificity, Predictive
values.
▪Others! (will be covered in research course)
Steps of Data
Analysis
1: ASK
Formulate clinical
question
2: ACQUIRE
Searching the data-
bases
3: ORGANIZE
and display
4: ANALYZE
Interpret properly
5: APPLY
Take action
Ask
Should be in PICO format
(clinical question).
Ask
You were setting in the clinic where a post
bariatric surgery teen girl came to ask
you: “Since I had bariatric surgery, do I
need iron supplement?”
How can you formulate clinical question
(PICO)?
Ask
P Population Do teen girls
I Intervention Who had bariatric surgery
C Comparison Compared to those who did not had the surgery
O Outcome Need iron supplementation
Mother of 4 years old boy told you;
ibuprofen is better in reducing fever
than paracetamol.
A 55 year-old smoker for more than
10 years request from you to do MRI
chest to check if he has lung cancer,
but you think CT chest will be enough.
Ask
Ask PICO!
Ask PICO!
Ask
To identify the important
KEYWORDS in searching.
Mother of 4 years old boy told you; ibuprofen is better in
reducing fever than paracetamol.
▪ PICO: In 4 years old boy, does paracetamol compared
to ibuprofen better reduce fever?
▪ KEYWARDS: Boy, paracetamol, ibuprofen, fever
Ask
Acquire & Organize
Searching the latest literature
about the medical condition.
This includes pubmed data-
base, Cochrane data-base…
Analyze
Interpret the data presented
correctly and understand its
biostatistical purpose.
Apply
Apply your analyzed data on
your patient appropriately
(benefit overweight risk, and
cost effective).
Data Interpretation
Prevalence
What is prevalence?
It is the proportion of a particular population found to be
affected by a medical condition compared to all population
Importance of prevalence:
Gives an estimated magnitude and burden of the medical
problem within the population. This will help for future
health planning and resource allocation.
Prevalence
Types of prevalence:
Point Prevalence
A prevalence that occurs on specific time. Example the
prevalence of DM in KSA is 24% in 2015
Period Prevalence
A prevalence that occurs over period of time. Example
the prevalence of MersCoV in KSA is 0.4% from 2014 -
2017
Prevalence
Calculation:
Number of all cases
Total population
X 100
Incidence
What is incidence?
It is the proportion of occurrence of new medical condition
within population at risk at a given time.
Importance of incidence:
The incidence helps in studying risk factors within the
population.
Calculation:
Number of new cases
Population at risk
X 100
Incidence
Question #1A:
On October 2017 in a village of 10,000 population, you found that
250 people have HBV infection. You raised a campaign to screen for
HBV infection and you discovered 200 new cases.
Calculate prevalence?
Examples
Question #1A:
On October 2017 in a village of 10,000 population, you found that
250 people have HBV infection. You raised a campaign to screen for
HBV infection and you discovered 200 new cases.
Calculate prevalence?
Examples
Number of all cases
Total population
X 100
Question #1A:
On October 2017 in a village of 10,000 population, you found that
250 people have HBV infection. You raised a campaign to screen for
HBV infection and you discovered 200 new cases.
Calculate prevalence?
Examples
250 + 200
10,000
X 100 = 4.5%
Question #1B:
On October 2017 in a village of 10,000 population, you found that
250 people have HBV infection. You raised a campaign to screen for
HBV infection and you discovered 200 new cases.
Calculate incidence?
Examples
Question #1B:
On October 2017 in a village of 10,000 population, you found that
250 people have HBV infection. You raised a campaign to screen for
HBV infection and you discovered 200 new cases.
Calculate incidence?
Examples
Number of new cases
Population at risk
X 100
Question #1B:
On October 2017 in a village of 10,000 population, you found that
250 people have HBV infection. You raised a campaign to screen for
HBV infection and you discovered 200 new cases.
Calculate incidence?
Examples
200
10,000 - 250
X 100 = 2.05%
Question #2A:
On December 2011 in a city of 100,000 population, you found that
450 people have HIV infection. You raised a campaign to screen for
HIV infection and you discovered 300 new cases.
Calculate prevalence?
Examples
Question #2A:
On December 2011 in a city of 100,000 population, you found that
450 people have HIV infection. You raised a campaign to screen for
HIV infection and you discovered 300 new cases.
Calculate prevalence?
Examples
Number of all cases
Total population
X 100
Question #2A:
On December 2011 in a city of 100,000 population, you found that
450 people have HIV infection. You raised a campaign to screen for
HIV infection and you discovered 300 new cases.
Calculate prevalence?
Examples
450 + 300
100,000
X 100 = 0.75%
Question #2B:
On December 2011 in a city of 100,000 population, you found that
450 people have HIV infection. You raised a campaign to screen for
HIV infection and you discovered 300 new cases.
Calculate incidence?
Examples
Question #2B:
On December 2011 in a city of 100,000 population, you found that
450 people have HIV infection. You raised a campaign to screen for
HIV infection and you discovered 300 new cases.
Calculate incidence?
Examples
Number of new cases
Population at risk
X 100
Question #2B:
On December 2011 in a city of 100,000 population, you found that
450 people have HIV infection. You raised a campaign to screen for
HIV infection and you discovered 300 new cases.
Calculate incidence?
Examples
300
100,000 - 450
X 100 = 0.3%
During the previous HIV
screening campaign, you
noticed some negative results.
Can you safely tell these
patients that they are free
from HIV infection?
Sensitivity
The probability of the test to be positive in those
who have the disease [TRUE POSITIVE] to all
diseased cases.
Specificity
The probability of the test to be negative in those
who are healthy [TRUE NEGATIVE] to all healthy
cases.
Gold standard
(disease)
AbsentPresent
Positive
Index
test Negative
2 X 2 Table
True Positive (TP)
False Negative (FN)
False Positive (FP)
True Negative (TN)
2 X 2 Table
Total
Gold standard
(disease)
AbsentPresent
a + bb (FP)a (TP)PositiveIndex
test c + dd (TN)c (FN)Negative
a+b+c+db + da + cTotal
SENSITIVITY
Sensitivity =
𝑎
𝑎 + 𝑐
2 X 2 Table
Total
Gold standard
(disease)
AbsentPresent
a + bb (FP)a (TP)PositiveIndex
test c + dd (TN)c (FN)Negative
a+b+c+db + da + cTotal
SPECIFICITY
Specificity =
𝑑
𝑏 + 𝑑
SnNout SpPin
SnNout
In HIGHLY Sensitive test, a Negative result rules Out the diagnosis;
i.e. False Negative is minimal or null.
Total
Gold standard
(disease)
AbsentPresent
2057198PositiveIndex
test 1971952Negative
402202200Total
Sensitivity =
𝑎
𝑎 + 𝑐
=
198
200
= 0.99 𝑡ℎ𝑎𝑡 𝑖𝑠 99%
SpPin
In HIGHLY Specific test, a Positive result rules In the diagnosis; i.e.
False Positive is minimal or null.
Total
Gold standard
(disease)
AbsentPresent
2057198PositiveIndex
test 1971952Negative
402202200Total
Specificity =
195
202
= 0.965 𝑡ℎ𝑎𝑡 𝑖𝑠 96.5%=
𝑑
𝑏 + 𝑑
The probability of being diseased in individual with
positive test, compared to all positive tests.
Positive predictive valuePPV
The probability of being healthy in individual with
negative test, compared to all negative tests.
Negative predictive valueNPV
2 X 2 Table
Total
Gold standard
(disease)
AbsentPresent
a + bb (FP)a (TP)PositiveIndex
test c + dd (TN)c (FN)Negative
a+b+c+db + da + cTotal
PPV
PPV =
𝑎
𝑎 + 𝑏
2 X 2 Table
Total
Gold standard
(disease)
AbsentPresent
a + bb (FP)a (TP)PositiveIndex
test c + dd (TN)c (FN)Negative
a+b+c+db + da + cTotal
NPV
NPV =
𝑑
𝑐 + 𝑑
Total
Gold standard
(disease)
AbsentPresent
a + bb (FP)a (TP)PositiveIndex
test c + dd (TN)c (FN)Negative
a+b+c+db + da + cTotal
Sn Sp
PPV
NPV
Let’s go back to the scenario
56 year-old woman came to you to discuss her
mammogram study result. Her result was
positive and so she asked you “Oh, do I have
breast cancer doctor?”
How will you respond to this question?
PPV or SpPin
Continue…
You searched the literature and you found that the
prevalence of breast cancer in KSA in 2015 was 14% among
women age 45-59 years old. Further more, you knew that
the sensitivity of mammogram is about 98% at this age
group while the specificity is 82%.
Can You answer the woman previous question now?
Direct proportion
to PPV
During the previous HIV
screening campaign, you
noticed some negative results.
Can you safely tell these
patients that they are free
from HIV infection?
NPV or SnNout
Summary
Prevalence
The proportion of a particular population found to be
affected by a medical condition to all population.
Incidence
It is the proportion of occurrence of new medical
condition within population at risk at a given time.
Sensitivity
The probability of the test to be positive in those who
have the disease to all diseased cases.
Specificity
The probability of the test to be negative in those who
are healthy to all healthy cases.
Summary
PPV
The probability of being diseased in individual with
positive test, compared to all positive tests.
NPV
The probability of being healthy in individual with
negative test, compared to all negative tests.
Summary
Analyzing data in health care Dr.Majdi

More Related Content

What's hot

De Finetti meets Popper
De Finetti meets PopperDe Finetti meets Popper
De Finetti meets Popper
Stephen Senn
 

What's hot (20)

Vaccine trials in the age of COVID-19
Vaccine trials in the age of COVID-19Vaccine trials in the age of COVID-19
Vaccine trials in the age of COVID-19
 
On being Bayesian
On being BayesianOn being Bayesian
On being Bayesian
 
Clinical trials: three statistical traps for the unwary
Clinical trials: three statistical traps for the unwaryClinical trials: three statistical traps for the unwary
Clinical trials: three statistical traps for the unwary
 
P values and the art of herding cats
P values  and the art of herding catsP values  and the art of herding cats
P values and the art of herding cats
 
P values and replication
P values and replicationP values and replication
P values and replication
 
Minimally important differences
Minimally important differencesMinimally important differences
Minimally important differences
 
Risky Business: Risk communicat ion in the provider-patient encounter
Risky Business: Risk communicat ion in the provider-patient encounterRisky Business: Risk communicat ion in the provider-patient encounter
Risky Business: Risk communicat ion in the provider-patient encounter
 
Minimally important differences v2
Minimally important differences v2Minimally important differences v2
Minimally important differences v2
 
Personalised medicine a sceptical view
Personalised medicine a sceptical viewPersonalised medicine a sceptical view
Personalised medicine a sceptical view
 
The Seven Habits of Highly Effective Statisticians
The Seven Habits of Highly Effective StatisticiansThe Seven Habits of Highly Effective Statisticians
The Seven Habits of Highly Effective Statisticians
 
Why I hate minimisation
Why I hate minimisationWhy I hate minimisation
Why I hate minimisation
 
What is your question
What is your questionWhat is your question
What is your question
 
De Finetti meets Popper
De Finetti meets PopperDe Finetti meets Popper
De Finetti meets Popper
 
P value wars
P value warsP value wars
P value wars
 
Biostatistics Workshop: Regression
Biostatistics Workshop: RegressionBiostatistics Workshop: Regression
Biostatistics Workshop: Regression
 
Placebos in medical research
Placebos in medical researchPlacebos in medical research
Placebos in medical research
 
A box-jenkins sarima analysis of dysentery cases in children aged below five ...
A box-jenkins sarima analysis of dysentery cases in children aged below five ...A box-jenkins sarima analysis of dysentery cases in children aged below five ...
A box-jenkins sarima analysis of dysentery cases in children aged below five ...
 
Is ignorance bliss
Is ignorance blissIs ignorance bliss
Is ignorance bliss
 
NNTs, responder analysis & overlap measures
NNTs, responder analysis & overlap measuresNNTs, responder analysis & overlap measures
NNTs, responder analysis & overlap measures
 
The challenge of small data
The challenge of small dataThe challenge of small data
The challenge of small data
 

Similar to Analyzing data in health care Dr.Majdi

Statistics tests and Probablity
Statistics tests and ProbablityStatistics tests and Probablity
Statistics tests and Probablity
Abdul Wasay Baloch
 
Introduction to stats important for third proff and hivhly recommended for no...
Introduction to stats important for third proff and hivhly recommended for no...Introduction to stats important for third proff and hivhly recommended for no...
Introduction to stats important for third proff and hivhly recommended for no...
udayaditya6446
 
Excelsior College PBH 321 Page 1 CASE-CONTROL STU.docx
Excelsior College PBH 321    Page 1 CASE-CONTROL STU.docxExcelsior College PBH 321    Page 1 CASE-CONTROL STU.docx
Excelsior College PBH 321 Page 1 CASE-CONTROL STU.docx
gitagrimston
 
OAJ presentation final draft
OAJ presentation final draftOAJ presentation final draft
OAJ presentation final draft
Brian Eisen
 

Similar to Analyzing data in health care Dr.Majdi (20)

Screening of Diseases
Screening of DiseasesScreening of Diseases
Screening of Diseases
 
8 screening.pptxscreening.pptxscreening.
8 screening.pptxscreening.pptxscreening.8 screening.pptxscreening.pptxscreening.
8 screening.pptxscreening.pptxscreening.
 
Evidence Based Diagnosis
Evidence Based DiagnosisEvidence Based Diagnosis
Evidence Based Diagnosis
 
Dr swe swe latt screening for slideshare
Dr swe swe latt screening for slideshareDr swe swe latt screening for slideshare
Dr swe swe latt screening for slideshare
 
Statistics tests and Probablity
Statistics tests and ProbablityStatistics tests and Probablity
Statistics tests and Probablity
 
P-values in crisis
P-values in crisisP-values in crisis
P-values in crisis
 
Screening test (basic concepts)
Screening test (basic concepts)Screening test (basic concepts)
Screening test (basic concepts)
 
[Workshop] The science of screening in Psycho-oncology (Oct10)
[Workshop]  The science of screening in Psycho-oncology (Oct10)[Workshop]  The science of screening in Psycho-oncology (Oct10)
[Workshop] The science of screening in Psycho-oncology (Oct10)
 
Clinical Advances In STIs (Sexually Transmitted Infections) CME 2018
Clinical Advances In STIs (Sexually Transmitted Infections) CME 2018Clinical Advances In STIs (Sexually Transmitted Infections) CME 2018
Clinical Advances In STIs (Sexually Transmitted Infections) CME 2018
 
Evidence-Based Medicine Overview
Evidence-Based Medicine OverviewEvidence-Based Medicine Overview
Evidence-Based Medicine Overview
 
Mesurement of morbidity (prevalence) presentation
Mesurement of morbidity (prevalence)   presentationMesurement of morbidity (prevalence)   presentation
Mesurement of morbidity (prevalence) presentation
 
Statistics in clinical and translational research common pitfalls
Statistics in clinical and translational research  common pitfallsStatistics in clinical and translational research  common pitfalls
Statistics in clinical and translational research common pitfalls
 
Introduction to stats important for third proff and hivhly recommended for no...
Introduction to stats important for third proff and hivhly recommended for no...Introduction to stats important for third proff and hivhly recommended for no...
Introduction to stats important for third proff and hivhly recommended for no...
 
Screening
ScreeningScreening
Screening
 
Slideshare cork skep3
Slideshare cork skep3Slideshare cork skep3
Slideshare cork skep3
 
Excelsior College PBH 321 Page 1 CASE-CONTROL STU.docx
Excelsior College PBH 321    Page 1 CASE-CONTROL STU.docxExcelsior College PBH 321    Page 1 CASE-CONTROL STU.docx
Excelsior College PBH 321 Page 1 CASE-CONTROL STU.docx
 
P-values the gold measure of statistical validity are not as reliable as many...
P-values the gold measure of statistical validity are not as reliable as many...P-values the gold measure of statistical validity are not as reliable as many...
P-values the gold measure of statistical validity are not as reliable as many...
 
OAJ presentation final draft
OAJ presentation final draftOAJ presentation final draft
OAJ presentation final draft
 
Evaluating the Medical Literature
Evaluating the Medical LiteratureEvaluating the Medical Literature
Evaluating the Medical Literature
 
HINZ Education Workshop: Evidence Based Practice
HINZ Education Workshop: Evidence Based PracticeHINZ Education Workshop: Evidence Based Practice
HINZ Education Workshop: Evidence Based Practice
 

More from Dr. Majdi Al Jasim

More from Dr. Majdi Al Jasim (13)

Growth Charts Interpretation DrMajdi
Growth Charts Interpretation DrMajdiGrowth Charts Interpretation DrMajdi
Growth Charts Interpretation DrMajdi
 
Insulin therapy in primary health care DrMajdi
Insulin therapy in primary health care DrMajdiInsulin therapy in primary health care DrMajdi
Insulin therapy in primary health care DrMajdi
 
DM Complications DrMajdi
DM Complications DrMajdiDM Complications DrMajdi
DM Complications DrMajdi
 
Research literature review dr majdi
Research literature review dr majdiResearch literature review dr majdi
Research literature review dr majdi
 
Critical Appraisal of systematic review and meta analysis articles
Critical Appraisal of systematic review and meta analysis articlesCritical Appraisal of systematic review and meta analysis articles
Critical Appraisal of systematic review and meta analysis articles
 
Practice managment dr majdi
Practice managment dr majdiPractice managment dr majdi
Practice managment dr majdi
 
Spss series - data entry and coding
Spss series - data entry and codingSpss series - data entry and coding
Spss series - data entry and coding
 
Questionnaire data collection tool dr majdi
Questionnaire data collection tool dr majdiQuestionnaire data collection tool dr majdi
Questionnaire data collection tool dr majdi
 
Selecting research topic dr majdi
Selecting research topic dr majdiSelecting research topic dr majdi
Selecting research topic dr majdi
 
Research inclusion and exclusion criteria DrMajdi
Research inclusion and exclusion criteria DrMajdiResearch inclusion and exclusion criteria DrMajdi
Research inclusion and exclusion criteria DrMajdi
 
سبل الوقاية من فيروس كورونا
سبل الوقاية من فيروس كوروناسبل الوقاية من فيروس كورونا
سبل الوقاية من فيروس كورونا
 
RCT Critical Appraisal - Results
RCT Critical Appraisal - ResultsRCT Critical Appraisal - Results
RCT Critical Appraisal - Results
 
RCT Critical Appraisal - Validity
RCT Critical Appraisal - ValidityRCT Critical Appraisal - Validity
RCT Critical Appraisal - Validity
 

Recently uploaded

Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 

Recently uploaded (20)

ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptx
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
Magic bus Group work1and 2 (Team 3).pptx
Magic bus Group work1and 2 (Team 3).pptxMagic bus Group work1and 2 (Team 3).pptx
Magic bus Group work1and 2 (Team 3).pptx
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 

Analyzing data in health care Dr.Majdi

  • 1. Analyzing Data in Health Care Dr. Majdi N. Al-Jasim SBFM, ABFM Consultant Family Medicine PCFCM - AlAhsa
  • 2. Scenario 56 year-old woman came to you to discuss her mammogram study result. Her result was positive and so she asked you “Oh, do I have breast cancer doctor?” How will you respond to this question?
  • 3. Continue… You searched the literature and you found that the prevalence of breast cancer in KSA in 2015 was 14% among women age 45-59 years old. Further more, you knew that the sensitivity of mammogram is about 98% at this age group while the specificity is 82%. Can You answer the woman previous question now? YOU!
  • 4. OBJECTIVES 1. To discuss the general steps of data analysis in health care. 2. To discuss the important fundamental terms used in data analysis of health problem, lab or imaging studies: ▪Prevalence, Incidence, Sensitivity, Specificity, Predictive values. ▪Others! (will be covered in research course)
  • 5. Steps of Data Analysis 1: ASK Formulate clinical question 2: ACQUIRE Searching the data- bases 3: ORGANIZE and display 4: ANALYZE Interpret properly 5: APPLY Take action
  • 6. Ask Should be in PICO format (clinical question).
  • 7. Ask You were setting in the clinic where a post bariatric surgery teen girl came to ask you: “Since I had bariatric surgery, do I need iron supplement?” How can you formulate clinical question (PICO)?
  • 8. Ask P Population Do teen girls I Intervention Who had bariatric surgery C Comparison Compared to those who did not had the surgery O Outcome Need iron supplementation
  • 9. Mother of 4 years old boy told you; ibuprofen is better in reducing fever than paracetamol. A 55 year-old smoker for more than 10 years request from you to do MRI chest to check if he has lung cancer, but you think CT chest will be enough. Ask Ask PICO! Ask PICO!
  • 10. Ask To identify the important KEYWORDS in searching.
  • 11. Mother of 4 years old boy told you; ibuprofen is better in reducing fever than paracetamol. ▪ PICO: In 4 years old boy, does paracetamol compared to ibuprofen better reduce fever? ▪ KEYWARDS: Boy, paracetamol, ibuprofen, fever Ask
  • 12. Acquire & Organize Searching the latest literature about the medical condition. This includes pubmed data- base, Cochrane data-base…
  • 13. Analyze Interpret the data presented correctly and understand its biostatistical purpose.
  • 14. Apply Apply your analyzed data on your patient appropriately (benefit overweight risk, and cost effective).
  • 16. Prevalence What is prevalence? It is the proportion of a particular population found to be affected by a medical condition compared to all population Importance of prevalence: Gives an estimated magnitude and burden of the medical problem within the population. This will help for future health planning and resource allocation.
  • 17. Prevalence Types of prevalence: Point Prevalence A prevalence that occurs on specific time. Example the prevalence of DM in KSA is 24% in 2015 Period Prevalence A prevalence that occurs over period of time. Example the prevalence of MersCoV in KSA is 0.4% from 2014 - 2017
  • 18. Prevalence Calculation: Number of all cases Total population X 100
  • 19. Incidence What is incidence? It is the proportion of occurrence of new medical condition within population at risk at a given time. Importance of incidence: The incidence helps in studying risk factors within the population.
  • 20. Calculation: Number of new cases Population at risk X 100 Incidence
  • 21. Question #1A: On October 2017 in a village of 10,000 population, you found that 250 people have HBV infection. You raised a campaign to screen for HBV infection and you discovered 200 new cases. Calculate prevalence? Examples
  • 22. Question #1A: On October 2017 in a village of 10,000 population, you found that 250 people have HBV infection. You raised a campaign to screen for HBV infection and you discovered 200 new cases. Calculate prevalence? Examples Number of all cases Total population X 100
  • 23. Question #1A: On October 2017 in a village of 10,000 population, you found that 250 people have HBV infection. You raised a campaign to screen for HBV infection and you discovered 200 new cases. Calculate prevalence? Examples 250 + 200 10,000 X 100 = 4.5%
  • 24. Question #1B: On October 2017 in a village of 10,000 population, you found that 250 people have HBV infection. You raised a campaign to screen for HBV infection and you discovered 200 new cases. Calculate incidence? Examples
  • 25. Question #1B: On October 2017 in a village of 10,000 population, you found that 250 people have HBV infection. You raised a campaign to screen for HBV infection and you discovered 200 new cases. Calculate incidence? Examples Number of new cases Population at risk X 100
  • 26. Question #1B: On October 2017 in a village of 10,000 population, you found that 250 people have HBV infection. You raised a campaign to screen for HBV infection and you discovered 200 new cases. Calculate incidence? Examples 200 10,000 - 250 X 100 = 2.05%
  • 27. Question #2A: On December 2011 in a city of 100,000 population, you found that 450 people have HIV infection. You raised a campaign to screen for HIV infection and you discovered 300 new cases. Calculate prevalence? Examples
  • 28. Question #2A: On December 2011 in a city of 100,000 population, you found that 450 people have HIV infection. You raised a campaign to screen for HIV infection and you discovered 300 new cases. Calculate prevalence? Examples Number of all cases Total population X 100
  • 29. Question #2A: On December 2011 in a city of 100,000 population, you found that 450 people have HIV infection. You raised a campaign to screen for HIV infection and you discovered 300 new cases. Calculate prevalence? Examples 450 + 300 100,000 X 100 = 0.75%
  • 30. Question #2B: On December 2011 in a city of 100,000 population, you found that 450 people have HIV infection. You raised a campaign to screen for HIV infection and you discovered 300 new cases. Calculate incidence? Examples
  • 31. Question #2B: On December 2011 in a city of 100,000 population, you found that 450 people have HIV infection. You raised a campaign to screen for HIV infection and you discovered 300 new cases. Calculate incidence? Examples Number of new cases Population at risk X 100
  • 32. Question #2B: On December 2011 in a city of 100,000 population, you found that 450 people have HIV infection. You raised a campaign to screen for HIV infection and you discovered 300 new cases. Calculate incidence? Examples 300 100,000 - 450 X 100 = 0.3%
  • 33. During the previous HIV screening campaign, you noticed some negative results. Can you safely tell these patients that they are free from HIV infection?
  • 34.
  • 35. Sensitivity The probability of the test to be positive in those who have the disease [TRUE POSITIVE] to all diseased cases. Specificity The probability of the test to be negative in those who are healthy [TRUE NEGATIVE] to all healthy cases.
  • 36. Gold standard (disease) AbsentPresent Positive Index test Negative 2 X 2 Table True Positive (TP) False Negative (FN) False Positive (FP) True Negative (TN)
  • 37. 2 X 2 Table Total Gold standard (disease) AbsentPresent a + bb (FP)a (TP)PositiveIndex test c + dd (TN)c (FN)Negative a+b+c+db + da + cTotal SENSITIVITY Sensitivity = 𝑎 𝑎 + 𝑐
  • 38. 2 X 2 Table Total Gold standard (disease) AbsentPresent a + bb (FP)a (TP)PositiveIndex test c + dd (TN)c (FN)Negative a+b+c+db + da + cTotal SPECIFICITY Specificity = 𝑑 𝑏 + 𝑑
  • 40. SnNout In HIGHLY Sensitive test, a Negative result rules Out the diagnosis; i.e. False Negative is minimal or null. Total Gold standard (disease) AbsentPresent 2057198PositiveIndex test 1971952Negative 402202200Total Sensitivity = 𝑎 𝑎 + 𝑐 = 198 200 = 0.99 𝑡ℎ𝑎𝑡 𝑖𝑠 99%
  • 41. SpPin In HIGHLY Specific test, a Positive result rules In the diagnosis; i.e. False Positive is minimal or null. Total Gold standard (disease) AbsentPresent 2057198PositiveIndex test 1971952Negative 402202200Total Specificity = 195 202 = 0.965 𝑡ℎ𝑎𝑡 𝑖𝑠 96.5%= 𝑑 𝑏 + 𝑑
  • 42. The probability of being diseased in individual with positive test, compared to all positive tests. Positive predictive valuePPV The probability of being healthy in individual with negative test, compared to all negative tests. Negative predictive valueNPV
  • 43. 2 X 2 Table Total Gold standard (disease) AbsentPresent a + bb (FP)a (TP)PositiveIndex test c + dd (TN)c (FN)Negative a+b+c+db + da + cTotal PPV PPV = 𝑎 𝑎 + 𝑏
  • 44. 2 X 2 Table Total Gold standard (disease) AbsentPresent a + bb (FP)a (TP)PositiveIndex test c + dd (TN)c (FN)Negative a+b+c+db + da + cTotal NPV NPV = 𝑑 𝑐 + 𝑑
  • 45. Total Gold standard (disease) AbsentPresent a + bb (FP)a (TP)PositiveIndex test c + dd (TN)c (FN)Negative a+b+c+db + da + cTotal Sn Sp PPV NPV
  • 46. Let’s go back to the scenario 56 year-old woman came to you to discuss her mammogram study result. Her result was positive and so she asked you “Oh, do I have breast cancer doctor?” How will you respond to this question? PPV or SpPin
  • 47. Continue… You searched the literature and you found that the prevalence of breast cancer in KSA in 2015 was 14% among women age 45-59 years old. Further more, you knew that the sensitivity of mammogram is about 98% at this age group while the specificity is 82%. Can You answer the woman previous question now? Direct proportion to PPV
  • 48. During the previous HIV screening campaign, you noticed some negative results. Can you safely tell these patients that they are free from HIV infection? NPV or SnNout
  • 49. Summary Prevalence The proportion of a particular population found to be affected by a medical condition to all population. Incidence It is the proportion of occurrence of new medical condition within population at risk at a given time.
  • 50. Sensitivity The probability of the test to be positive in those who have the disease to all diseased cases. Specificity The probability of the test to be negative in those who are healthy to all healthy cases. Summary
  • 51. PPV The probability of being diseased in individual with positive test, compared to all positive tests. NPV The probability of being healthy in individual with negative test, compared to all negative tests. Summary